Brummer Multi-Strategy’s Abivax ABVX Stock Holding History

Brummer Multi-Strategy’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,428	Closed	-$2.5M	–	2
2026 Q1	$2.5M	Buy	22,428 +8,053	+56%	+$953K	10.4%	4
2025 Q4	$1.94M	Buy	+14,375	New	+$1.57M	11.72%	4

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Jupiter Topco New York $245B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brummer Multi-Strategy's ABVX Position: Q2 2026 in Review

Brummer Multi-Strategy sold out of Abivax (ABVX) in Q2 2026, closing a stake of 22,428 shares — an estimated $2.5M sold.

Brummer Multi-Strategy first reported a position in ABVX in Q4 2025 and held it in 2 quarters. The position peaked at $2.5M in Q1 2026. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

Brummer Multi-Strategy reported no remaining Abivax position as of Q2 2026 after selling out during the quarter.
Brummer Multi-Strategy sold 22,428 Abivax shares in Q2 2026, an estimated $2.5M.
Brummer Multi-Strategy first reported a position in Abivax in Q4 2025 and held it in 2 quarters.
Brummer Multi-Strategy's Abivax position peaked at $2.5M in Q1 2026.
302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Brummer Multi-Strategy's 13F filing for Q2 2026, filed 23 Jul 2026.